Comparison between Influx Healthtech IPO and Western Overseas Study Abroad IPO.
Influx Healthtech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Western Overseas Study Abroad IPO is a SME Fixed Price proposed to list at BSE SME.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Rarever Financial Advisors Pvt.Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Influx Healthtech IPO is up to ₹55.63 Cr whereas the issue size of the Western Overseas Study Abroad IPO is up to ₹9.56 Cr. The final issue price of Influx Healthtech IPO is ₹96.00 per share and of Western Overseas Study Abroad IPO is ₹56.00 per share.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | |
| Issue Price (Upper) | ₹96.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹56.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 46,94,400 shares | 17,08,000 shares |
| Fresh Issue Size (Amount) | up to ₹45.07 Cr | up to ₹9.56 Cr |
| OFS Issue Size | 11,00,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹10.56 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,94,800 shares | 17,08,000 shares |
| Issue Size Total (Amount) | up to ₹55.63 Cr | up to ₹9.56 Cr |
Influx Healthtech IPO opens on Jun 18, 2025, while Western Overseas Study Abroad IPO opens on Dec 04, 2025. The closing date of Influx Healthtech IPO and Western Overseas Study Abroad IPO is Jun 20, 2025, and Dec 08, 2025, respectively.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2025 | |
| Issue Open | Jun 18, 2025 | Dec 04, 2025 |
| Issue Close | Jun 20, 2025 | Dec 08, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2025 | Dec 09, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2025 | Dec 10, 2025 |
| Credit of Share (Tentative) | Jun 24, 2025 | Dec 10, 2025 |
| Listing date (Tentative) | Jun 25, 2025 | Dec 11, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2025 | |
| Anchor Lockin End date 2 | Sep 21, 2025 |
Influx Healthtech IPO P/E ratio is 13.04, as compared to Western Overseas Study Abroad IPO P/E ratio of 10.67.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Influx Healthtech Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Western Overseas Study Abroad Ltd.'s revenue increased by 13% and profit after tax (PAT) rose by 86% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.85 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 70.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.04 | 10.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹222.24 Cr. | ₹33.67 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.98% | 40.18% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 49.17% | 37.63% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | 0.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.36 | ₹5.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.98% | 33.86% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Influx Healthtech IPO Retail Individual Investors (RII) are offered 20,29,200 shares while in Western Overseas Study Abroad IPO retail investors are offered 20,29,200 shares. Qualified Institutional Buyers (QIB) are offered 11,59,200 shares in Influx Healthtech IPO and 0 shares in Western Overseas Study Abroad IPO.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,36,400 shares | 0 shares |
| Market Maker Reservation | 3,06,000 shares | 90,000 shares |
| QIB | 11,59,200 shares | 0 shares |
| NII | 8,70,000 shares | 8,54,000 shares |
| RII | 20,29,200 shares | 8,54,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 57,94,800 shares | 17,08,000 shares |
Influx Healthtech IPO subscribed 201.35x in total, whereas Western Overseas Study Abroad IPO subscribed 1.41x.
| Influx Healthtech IPO | Western Overseas Study Abroad IPO | |
|---|---|---|
| QIB (times) | 137.87x | |
| NII (times) | 481.10x | 0.39x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 117.68x | 2.43x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 201.35x | 1.41x |
